Opportunity timeline
In plain English
The Defense Health Agency is seeking pharmaceutical quotes for six newly approved drugs to consider for the Department of War Uniform Formulary. Potential agreements include Uniform Formulary Blanket Purchase Agreements and additional discount program agreements. A pre-quotation teleconference is scheduled for September 9, 2026; the RFQ lists the response deadline and contact details.
About this opportunity
The Department of War (DoW) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoW Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoW Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary…
Time remaining
Closes Sep 24, 2026
Related Opportunities

FY27 SIR-Spheres Y90 Resin Microspheres

FY27-28 Pediatric Flu Vaccines

FY27-28 Adult Flu Vaccines

Tacrolimus Capsules

FDG Radiopharmaceutical
Bid details are gathered and summarized automatically. Please verify details at the original source.
Ref No.
BS-7F6685

